Mark is an advisor to the Life Sciences investment team at Foresite, focusing on investment opportunities in life sciences and healthcare.
Mark joined Foresite from T-knife Therapeutics, where he was a member of the leadership team responsible for business development, strategic planning and finance. Previously, Mark held various positions at Genentech/Roche, supporting business development transactions, the late-stage portfolio, and early-stage R&D programs. Prior to joining Genentech, Mark spent several years at Wells Fargo in the Corporate Banking and Principal Investing groups. Mark received his bachelor’s degree from Emory University and an MBA from the University of California, Berkeley’s Haas School of Business.
